Literature DB >> 2432881

Structural analysis of acute-phase alpha 2-macroglobulin.

G J Beitel, A J Luft, D E Panrucker, F L Lorscheider.   

Abstract

High resolution images of rat acute-phase alpha 2-macroglobulin (AP alpha 2M) have been obtained by using dark-field electron microscopy. No staining or artifact-inducing procedures were used. Analysis of unfiltered electron microscope plates, exposed to minimal electron beam radiation, revealed highly contrasted particles of variable morphology with dimensions of approx. 19 nm X 14 nm. An electron-dense core with four to six projections could be seen. Two-fold symmetry was evident in selected images, supporting the four-subunit composition of the protein. Image processing and filtering confirmed the presence and configuration of the projections by demonstrating exact molecular dimensions of 16 nm X 9.5 nm and a shape with six projections like that of the Russian letter zh. SDS/polyacrylamide-gel electrophoresis revealed that this molecule was in the proteinase-bound form. C.d. data revealed a surprisingly low content of alpha-helical secondary structure (12%) and an atypically large content of beta-form structure (33%). Comparison of the amino acid compositions of AP alpha 2M and human alpha 2-macroglobulin indicated a high degree of homology between the two molecules. It is concluded that the conformation of rat AP alpha 2M, both at the molecular and secondary structural levels, is strikingly similar to that of human alpha 2-macroglobulin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432881      PMCID: PMC1147144          DOI: 10.1042/bj2380359

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  A simple ultraviolet spectrophotometric method for the determination of protein.

Authors:  W J WADDELL
Journal:  J Lab Clin Med       Date:  1956-08

3.  Determination of the helix and beta form of proteins in aqueous solution by circular dichroism.

Authors:  Y H Chen; J T Yang; K H Chau
Journal:  Biochemistry       Date:  1974-07-30       Impact factor: 3.162

4.  Relation between rat slow alpha-2-globulin and alpha-2-macroglobulin of other mammals.

Authors:  W G Heim
Journal:  Nature       Date:  1968-03-16       Impact factor: 49.962

5.  Structural analysis of human and bovine alpha-fetoprotein by electron microscopy, image processing, and circular dichroism.

Authors:  A J Luft; F L Lorscheider
Journal:  Biochemistry       Date:  1983-12-06       Impact factor: 3.162

6.  Identification and characterization of trypsin, chymotrypsin and elastase inhibitors in porcine serum.

Authors:  B R Weström
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-12

7.  Distribution of acute-phase alpha 2-macroglobulin in rat fetomaternal compartments.

Authors:  D E Panrucker; P C Lai; F L Lorscheider
Journal:  Am J Physiol       Date:  1983-08

8.  Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors.

Authors:  S L Gonias; A E Balber; W J Hubbard; S V Pizzo
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

9.  Bovine fetus-specific serum proteins. Purification and characterization of alpha1-fetoprotein and immunological identification of alpha2- and beta-fetoproteins.

Authors:  P C Lai; E H Peters; F L Lorscheider
Journal:  Biochim Biophys Acta       Date:  1978-07-21

10.  Electron microscopy of the conformational changes of alpha 2-macroglobulin from human plasma.

Authors:  J Tapon-Bretaudiére; A Bros; E Couture-Tosi; E Delain
Journal:  EMBO J       Date:  1985-01       Impact factor: 11.598

View more
  1 in total

1.  Evidence for an alpha 2-macroglobulin with complement-inhibiting activity in rat serum.

Authors:  R Bellott; A Bon; J Lestage; J P Giroud; P Chateaureynaud
Journal:  Int J Exp Pathol       Date:  1991-04       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.